Gene: ZNF34
Official Full Name: zinc finger protein 34provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25900 | ZNF34 Knockout cell line (HeLa) | Human | ZNF34 | 1:3~1:6 | Negative | Online Inquiry |
KO25901 | ZNF34 Knockout cell line (HCT 116) | Human | ZNF34 | 1:2~1:4 | Negative | Online Inquiry |
KO25902 | ZNF34 Knockout cell line (HEK293) | Human | ZNF34 | 1:3~1:6 | Negative | Online Inquiry |
KO25903 | ZNF34 Knockout cell line (A549) | Human | ZNF34 | 1:3~1:4 | Negative | Online Inquiry |
ZNF34 Gene Knockout Cell Lines are advanced biological tools specifically designed for the targeted study of the ZNF34 gene, which is known to play a role in various cellular processes, including transcription regulation and cell differentiation. Utilizing CRISPR/Cas9 technology, these cell lines allow researchers to precisely inactivate the ZNF34 gene, providing an invaluable platform for studying gene function and its implications in disease modeling.
The mechanism of action involves the introduction of CRISPR-induced double-strand breaks in the ZNF34 gene sequence, leading to either large deletions or insertions through cellular repair processes. This knockout approach results in a loss-of-function phenotype, enabling detailed assessments of the physiological and pathological roles of ZNF34. By using these cell lines, researchers can elucidate the gene's contributions to mechanisms such as cell growth, apoptosis, and stress response, making them essential for both basic biological research and translational applications.
The scientific importance of ZNF34 Gene Knockout Cell Lines extends beyond academic inquiry; they are instrumental in preclinical studies for drug development and genetic disease research. By providing insights into disease mechanisms, these cell lines can aid in the identification of potential therapeutic targets, accelerating the path to clinical applications.
What sets our ZNF34 Gene Knockout Cell Lines apart from alternatives is their high specificity and reproducibility, coupled with our rigorous quality control processes. Each line is validated for gene knockout efficiency and phenotypic characterization to ensure reliability in experimental outcomes. This assurance empowers researchers and clinicians to confidently pursue experiments with consistent results.
The value of ZNF34 Gene Knockout Cell Lines lies in their capacity to facilitate groundbreaking discoveries and to enhance our understanding of complex biological networks. By choosing our product, researchers gain access to a proven resource that supports their innovations and contributes to advancements in therapeutic strategies.
With years of experience in developing high-quality genetic tools and a commitment to innovation, our company is dedicated to providing the scientific community with robust and reliable biological products that accelerate research and improve outcomes in cell and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.